Press release
Rising Cardiovascular Cases Fuel Demand For Advanced Heart Failure Solutions: Major Factor in the Transformation of the Congestive Heart Failure (CHF) Market in 2025
Congestive Heart Failure (CHF) Market Size
The market size for congestive heart failure (CHF) has seen substantial growth in recent years. It is expected to experience an expansion from $15.94 billion in 2024 to $17.10 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. The impressive growth seen in the historical period is a result of the increasing prevalence of the aging population, escalating occurrences of cardiovascular diseases, a heightened awareness about heart health, a rise in healthcare spending, and a growing demand for remote patient monitoring.
Over the coming years, the congestive heart failure (CHF) market is set to witness significant expansion, with predictions to reach $22.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The projected growth during this period can be credited to factors such as the growing use of digital health solutions, heightened instances of hypertension, increasing rates of obesity, improved patient results, and a heightened focus on individualized medicine. The forecast period will also see major trends such as advancements in diagnostic and treatment options, innovative strides in imaging technology, breakthroughs in therapeutic strategies, and progression in the field of wearable health devices.
What Key Elements Are Boosting Growth in the Congestive Heart Failure (CHF) Market?
There is an ascending trend in cardiovascular patients that is anticipated to accelerate the expansion of the congestive heart failure (CHF) market in the near future. Cardiovascular pertains to the blood vessels and heart, stressing their significance revolving around blood circulation and sustaining the body's overall wellness. The uplift in cardiovascular patients can be attributed to inactive lifestyles, poor food habits, ageing populace, and urbanization, consequently necessitating superior medicare and treatment remedies. Congestive heart failure (CHF) services cardiovascular patients by offering focused solutions that enhance heart proficiency, lessen indications and deter complications, ultimately uplifting patient care and general health. For example, the American College of Cardiology, a non-profit medical society based in the US, reported in January 2023 that cases of cardiovascular diseases escalated to 19.8 million in 2022. Furthermore, Eastern Europe has registered the highest mortality rate, standing at 553 deaths per 100,000. Given these factors, the surge in cardiovascular patients augments the development of the congestive heart failure (CHF) market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20730&type=smp
Who Are the Major Industry Players Fueling Congestive Heart Failure (CHF) Market Expansion?
Major companies operating in the congestive heart failure (CHF) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova
What Are the Latest Innovations in the Congestive Heart Failure (CHF) Market?
Leading corporations in the congestive heart failure (CHF) market are prioritizing breakthrough innovations such as single intracoronary infusion treatments. These cutting-edge treatments aim to improve heart functionalities and elevate the life quality of those with CHF. Employing the method of single intracoronary infusion, the medication is directly dispatched to the coronary artery to specifically target and treat ailments like CHF. For example, Bayer AG, a pharmaceutical enterprise based in Germany, and Asklepios Biopharmaceutical, Inc., a biotech firm stationed in the US, launched the GenePHIT Phase II trial for AB-1002, a potential gene-based therapy for CHF, in January 2024. This novel conceptualization employs a gene therapy approach to non-ischemic cardiomyopathy, providing a possible game-changer in CHF treatment via sophisticated genetic solutions. This trial is adaptive, placebo-controlled, and double-blind. It is set to include 90 to 150 participants who have maintained medical stability for a minimum of four weeks and have a left ventricular ejection fraction within the bracket of 15% to 35%.
How Is the Segmentation of the Congestive Heart Failure (CHF) Market Defined?
The congestive heart failure (CHF) market covered in this report is segmented -
1) By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2) By Treatment: Medication, Surgery
3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings
Subsegments:
1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF), Mild-to-moderate Reduced Ejection Fraction
2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF), Borderline Ejection Fraction (HFpEF)
3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure, Chronic Left-Sided Heart Failure
4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure, Chronic Right-Sided Heart Failure
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-chf-global-market-report
What Is the Leading Region in the Congestive Heart Failure (CHF) Market?
North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure (CHF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Congestive Heart Failure (CHF) Global Market Report?
- Market Size Analysis: Analyze the congestive heart failure (chf) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the congestive heart failure (chf) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall congestive heart failure (chf) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the congestive heart failure (chf) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20730
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cardiovascular Cases Fuel Demand For Advanced Heart Failure Solutions: Major Factor in the Transformation of the Congestive Heart Failure (CHF) Market in 2025 here
News-ID: 3875333 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for CHF
Work-ID AG: Tackling the Skills Shortage with CHF 4 Million and Skills-Manager
Thalwil, June 25, 2025 - Work-ID AG has closed a successful CHF 4 million financing round. The Thalwil-based start-up is launching Skills-Manager, a tool that shows companies which people fit both professionally and personally. Selecting by age, appearance, or gender? That was yesterday. Skills are the hard currency for smart companies.
Skills-Manager reveals who is a real fit
With Skills-Manager, companies gain a tool to identify and leverage people's skills. They can…
Global Congestive Heart Failure (CHF) Market Outlook 2025-2034: Trends, Innovati …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Congestive Heart Failure (CHF) Market Size and Projected Growth Rate?
The market scope for congestive heart failure (CHF) has seen robust augmentation in the past few years. The growth metrics show a burgeoning move from $15.94 billion in 2024 to $17.10 billion in 2025 with a compound annual growth rate (CAGR)…
Urgent Fundraising Campaign Launched to Pay CHF 4,000 Customs Fee and Reunite Mi …
Image: https://www.abnewswire.com/upload/2025/06/d380113ce38324782cf09e3032c4c76d.jpg
An urgent fundraising campaign has been launched by Miriam Schenk, a local resident facing a critical financial hurdle. With a CHF 4,000 customs bill standing between her and a package from her partner, a career soldier in the U.S. Army, Schenk is calling on kind-hearted donors, supporters, and philanthropists for assistance.
The package, sent by her boyfriend who is currently deployed, contains irreplaceable items of both emotional and financial value.…
Congestive Heart Failure (CHF) Treatment Devices Market Revenue Sizing Outlook A …
Allied Market Research added new research on Global Congestive Heart Failure (CHF) Treatment Devices Market- Global Opportunity Analysis and Industry Forecast, 2022-2030. The Congestive Heart Failure (CHF) Treatment Devices market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key…
Chronic Heart Failure (CHF) Drugs Industry Outlook and Forecast 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Chronic Heart Failure (CHF) Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Chronic Heart Failure (CHF) Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
GLOBAL INFO RESEARCH has lately published a new report titled, *Global Chronic Heart Failure (CHF) Drugs Market 2020 by Manufacturers, Regions,…
Screening Eagle raises CHF 55 million to protect the built world
Screening Eagle Technologies (SET), a cloud-based technology platform connecting sensors, software, and data for intelligent inspection of assets and infrastructure, is pleased to announce it has raised CHF 55 million in its first institutional round of equity funding.
Switzerland - April 3, 2020 -- Screening Eagle is on a mission to protect the built world. Massive economic value is at risk from aging global infrastructure and construction birth defects in…
